Immunoglobulin therapy, also known as normal human immunoglobulin (NHIG), is the use of a mixture of antibodies (immunoglobulins) to treat a number of health conditions.The first description of a subcutaneous route of administration for immunoglobulin therapy dates back to 1980, but for many years subcutaneous administration was considered to be a secondary choice, only to be considered when peripheral venous access was no longer possible or tolerable.Although intravenous was the preferred route for immunoglobulin therapy for many years, in 2006 the FDA approved the first preparation of immunoglobulin that was designed exclusively for subcutaneous use.
Based on the Subcutaneous Immunoglobulins market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Subcutaneous Immunoglobulins market covered in Chapter 5:
Kedrion S.p.A
Octapharma AG
LFB S.A.
Bio Products Laboratory Ltd.
CSL Limited
Grifols S.A.
Takeda Pharmaceutical Company Limited
Biotest AG
In Chapter 6, on the basis of types, the Subcutaneous Immunoglobulins market from 2015 to 2025 is primarily split into:
10% Purity
20% Purity
In Chapter 7, on the basis of applications, the Subcutaneous Immunoglobulins market from 2015 to 2025 covers:
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Subcutaneous Immunoglobulins. Industry analysis & Market Report on Subcutaneous Immunoglobulins is a syndicated market report, published as Global Subcutaneous Immunoglobulins Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Subcutaneous Immunoglobulins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.